Hovenoside G

2-[4,5-dihydroxy-2-[5-hydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol

QVKNFOCNXKZPMO-UHFFFAOYSA-N CHEBI:180856 0 Reactome links 1 studies
1 Observed studies
1 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
QVKNFOCNXKZPMO-UHFFFAOYSA-N
IUPAC name
2-[4,5-dihydroxy-2-[5-hydroxy-2-[[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-enyl)-19,21-dioxahexacyclo[18.2.1.01,14.02,11.05,10.015,20]tricosan-7-yl]oxy]-3-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
Preferred name
Hovenoside G
INN name
Synonym
ChEBI
CHEBI:180856

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles